GlassScriptPhysician profile
Srihari Ravi
NPI 1184626731
$1,813.98
in general payments reported to CMS, 2019-2025
21 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2022: $184 · 2023: $375 · 2024: $478 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $666.35 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $233.18 | 2019-2022 | |
| Abbott Laboratories | $201.00 | 2023-2024 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $94.70 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $93.85 | 2019-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $89.42 | 2019 | |
| Amgen INC. | $70.02 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $62.65 | 2019 | |
| Heartflow, INC. | $45.26 | 2019 | |
| Preventice Services, LLC | $42.83 | 2019 | |
| Abiomed | $38.22 | 2023-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.70 | 2023 | Jardiance |
| Novo Nordisk INC | $24.81 | 2024 | Wegovy |
| Siemens Medical Solutions USA, INC. | $22.72 | 2023 | C.Cam Imaging System |
| Impulse Dynamics (USA) INC. | $19.18 | 2023 | Optimizer |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $14.46 | 2019 | |
| Ekos Corporation | $13.96 | 2019 | |
| Amarin Pharma, INC. | $13.43 | 2019 | |
| Edwards Lifesciences Corporation | $12.52 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.00 | 2019 | |
| Pfizer INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srihari Ravi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.